Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

PATH is advancing health equity around the world

January 30, 2024
How does human milk banking help ensure child health?
November 20, 2023
In Kenya, Beatrice Oyugi is helping children reach their full potential
March 8, 2024
Celebrating women in the fight to end malaria

Stay informed and make a difference: Subscribe to PATH Insights for a fairer and healthier future

Featured Press Coverage

October 30, 2022
A pandemic silver lining in Senegal
The Atlantic
November 14, 2023
Opinion: Collaborative solutions key to advance universal health coverage
Devex
January 7, 2023
How India has emerged as a global leader in public health
Hindustan Times

Recent Press Coverage

  1. Milken receives $5 million grant to bolster routine immunization in countries facing conflict
    The Milken Institute School of Public Health at George Washington University announced a partnership with PATH, funded by the Bill & Melinda Gates Foundation, to enhance immunization in countries with conflict
    Published: April 2024
  2. Who loses when scientific research is locked behind paywalls?
    An article announcing the Gates Foundation’s refreshed open access and preprint policy highlights the experience of PATH’s Emmanuel Mugisha, who says researchers in low- and middle-income countries face daily barriers as a result of journal paywalls
    Published: March 2024
  3. Five things you need to know about the world’s latest weapon against bacterial meningitis
    The Men5CV (MenFive) pentavalent meningitis vaccine—the result of a 13-year development collaboration between Serum Institute of India and PATH—could help eliminate a leading cause of neurological disease and disability in sub-Saharan Africa.
    Published: March 2024
  4. Kent Campbell, Pivotal Figure in the Fight Against Malaria, Dies at 80
    The New York Times remembers Kent Campbell, the creator and first director of PATH’s Malaria Control and Elimination Partnership in Africa (MACEPA) program. Dr. Campbell is remembered for a legacy of lifesaving work over four decades in public health.
    Published: March 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

955 Item s
955 Item s
    Date
    From
    To
  1. PATH congratulates Thailand on granting conditional approval for emergency use to first locally produced COVID-19 vaccine
    The NDV-HXP-S COVID-19 vaccine produced by Thailand’s Government Pharmaceutical Organization (GPO) has the potential to be an affordable option that advances vaccine supply sustainability and pandemic preparedness.
    Published: January 2024
    Statement
  2. The World Health Organization prequalifies novel type 2 oral polio vaccine (nOPV2)
    Emergency use of nOPV2 has protected millions against polio. Prequalification will ensure broad, long-term accessibility.
    Published: January 2024
    Announcement
  3. CEPI and PATH strengthen partnership to accelerate development of vaccines against diseases with epidemic or pandemic potential
    Published: December 2023
    Press Release
  4. Commonwealth and PATH launch new accelerator to support climate and health innovations
    Published: December 2023
    Press Release
  5. PATH and partners host congressional briefing on child survival
    Published: November 2023
    Announcement
Previous
Next